ClinicalTrials.Veeva

Menu

"To Study the Impact of Balloon-occluded Retrograde Transvenous Obliteration (BRTO)/Plug Assisted Retrograde Transvenous Obliteration (PARTO) Mediated Portal Flow Modulation in Reduction of Ammonia and Improvement in Organ Volume and Functionality in Patients of Cirrhosis With LR Shunt

I

Institute of Liver and Biliary Sciences, India

Status

Unknown

Conditions

Liver Cirrhoses

Treatments

Procedure: Plug assisted retrograde transvenous obliteration/Balloon-occluded retrograde transvenous obliteration
Other: Standard Medical Treatment

Study type

Interventional

Funder types

Other

Identifiers

NCT04089878
ILBS-Cirrhosis-25

Details and patient eligibility

About

The informed consent will be obtained from the participants in the study. The study will be conducted on indoor patients, Department of Hepatology ILBS, New Delhi. This will be a Pilot study (sample size 25 cases in each arm) with 50% chances of each patient to randomized into each arm(1:1 randomization) .

Study Population - Patients with hepatic encephalopathy with LR shunt admitted in wards/HDU (High Dependency Unit)/LC ICU(Liver Coma ICU).

Study design-Randomized controlled Trial

Study period- 1 year.

Sample Size-Single Centre prospective RCT

  • Sample size- Pilot study (sample size 25 cases in each arm)
  • Follow up duration-6 months

Enrollment

50 estimated patients

Sex

All

Ages

18 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Child A and B cirrhotic patients with Gastro/lieno-renal shunt of >8 mm.
  • Covert or Overt HE
  • Age 18 to 70 years

Exclusion criteria

  • Intractable ascites
  • PVT (with 100 % block )or PV Cavernoma and splenic vein thrombosis
  • High risk esophageal varices (till eradicated)
  • HVPG >16 mm Hg
  • HCC
  • Pregnancy and lactation
  • Refusal to participate in the study

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

50 participants in 2 patient groups

PARTO/BRTO + SMT
Experimental group
Description:
PARTO/BRTO with SMT will be given.
Treatment:
Procedure: Plug assisted retrograde transvenous obliteration/Balloon-occluded retrograde transvenous obliteration
Standard Medical Treatment
Active Comparator group
Description:
Antibiotics, nutrition and supportive treatment
Treatment:
Other: Standard Medical Treatment

Trial contacts and locations

1

Loading...

Central trial contact

Dr Shiv Kumar Sarin, DM

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems